Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery

NCT01127581 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1358

Enrollment

INDUSTRY

Sponsor class

Conditions

Reducing Time to Vaginal Delivery
Cervical Ripening
Induction of Labor

Interventions

DRUG: MVI 200
DRUG: Dinoprostone Vaginal Insert (DVI)

Sponsor

Ferring Pharmaceuticals